|
HAE Haemonetics Corp 313143 |
| Balance Sheet |
|
Current Assets
|
$810,832,000.00 |
|
Assets
|
$2,365,400,000.00 |
|
Current Liabilities
|
$263,235,000.00 |
|
Equity
|
$837,101,000.00 |
|
Shares Out
|
45471313.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$52,323,000.00 |
|
Investing Cash Flow
|
$-22,234,000.00 |
| Market Analysis |
Market Cap
|
$4,920,905,492.86 |
|
Price
|
$108.22 |
|
BVPS
|
18.41 |
|
PB
|
5.88 |
|
EPS
|
0.73 |
|
PE
|
37.61 |
|
PS
|
3.62 |
|
FCF
|
$44,417,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:27 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:17 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-05 |
1.31 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
1.29 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
0.70 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
1.27 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HAE documents filed with the SEC.
HAE Filings
Clear
